Financings in Brief: Norland Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Norland Medical Systems: Files registration statement for a public offering of 2.25 mil. shares, including 1.5 mil. offered by the company and 750,000 by selling shareholders. Shares in the offering "give effect to the three-for-two split of the company's common stock effective June 13, 1996," the firm says. Norland, which distributes and services bone densitometers manufactured by Norland Corporation and Stratec Medizintechnik GmbH, recently acquired bone densitometer manufacturer and distributor Dove Medical ("The Gray Sheet" April 8, In Brief). UBS Securities and Pacific Growth Equities are co-managing the offering...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.